Genentech advanced the collaboration's first neuroscience target into a joint early discovery program, providing early ...

Recursion Pharmaceuticals' partnerships, notably with Genentech/Roche and Sanofi, have delivered $500M+ in milestone payments ...

Recursion, Roche, and its Genentech subsidiary have announced plans to co-develop a neuroscience discovery program based on ...

Recursion Pharmaceuticals (NASDAQ:RXRX) outlined progress across its clinical pipeline, drug-discovery partnerships and ...

We are no longer just discussing the potential of our platform." (CEO, President & Director Najat Khan) "We now have 5 clinical stage programs, including REC-4881 in FAP, where we have generated some ...

Recursion Pharmaceuticals, Inc. reported its Q2 2026 results, with revenue falling to US$7.67 million from US$19.22 million a ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Genentech advanced the collaboration's first neuroscience target into a joint early discovery program, providing early evidence that Recursion's platform can generate novel, biologically validated tar ...

Lilian Weng, who built OpenAI's safety team, is rejoining the lab to lead recursive self-improvement research — the ...

Through purposeful questioning, teachers can empower students to agree on norms that foster trust, belonging, and shared ...

ISC Class 12 Computer Science Syllabus: The CISCE (Council for the Indian School Certificate Examinations) has released the latest Class 12 Computer Science syllabus for the 2026-27 board exam. The ...

Note: the trade details cited in this article come from The Claude Portfolio account on X, a third-party account not ...